However, UnitedHealth Group and Amedisys allege the lawsuit essentially ignores the companies' proposed divestiture package. The company didn’t identify which locations would be sold ...

Amedisys has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a market cap of $3.03 billion, a PE ratio of 36.71, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73.

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing issued late ...

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

Yeti’s coolers, reusable water bottles and tumblers are some of the best. Camping enthusiasts, hikers and beachgoers alike love using its durable products all year round. Many even keep things ...

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

After eight-plus years of being out of production, Yeti announced that It was re-releasing a new suite of tan camo-colored items that brand aficionados had previously had to pay steep premiums on ...

If you buy from a link, we may earn a commission. Learn more Toward the end of last year, hot on the heels of its French press launch in May, Yeti somewhat quietly released another slow-process, ...

The Philadelphia Eagles cruised past the Kansas City Chiefs for a historic Super Bowl win on Sunday, so now is the perfect time to stock up on Eagles gear and other Super Bowl LIX merch. Those who ...

Notably, that list includes the Utah Yeti and Yetis, which is known as a fan — and organization — favorite. Where does Utah go from here? How does the timeline for a name announcement change?

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...